Introduce Terlipressin in Central Vein, Perc, New Tech 7

This code describes the administration of Terlipressin directly into a central vein, such as the superior vena cava or femoral vein, using a percutaneous approach. This procedure is performed to achieve a systemic effect of the medication, typically in critical care settings.

This code is used when Terlipressin is introduced via a central venous catheter for conditions like hepatorenal syndrome or bleeding esophageal varices. It specifically applies to the initial or primary administration of this drug through a central line.

• Ensure documentation clearly specifies a central venous access and percutaneous insertion.
• Verify that the drug administered is Terlipressin, as this code is drug-specific.
• This is a New Technology code, so confirm it is the most appropriate and current option for Terlipressin introduction.